Labshake search
Citations for Stemcell Technologies :
351 - 400 of 1319 citations for 5 Azepane 1 sulfonyl 2 methoxy benzoic acid since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Physiology 2020Quote: ... Undifferentiated hiPSCs were maintained on Vitronectin XF (5 μg/mL, Stem Cell Technologies) coated tissue culture dishes as per manufacturer recommendation with either mTeSR medium with supplementation or mTeSR PLUS medium with supplementation (Stem Cell Technologies) ...
-
bioRxiv - Developmental Biology 2021Quote: ... 300 U/mL of hyaluronidase and 5 mg/mL DNAse I (StemCell Technologies) under gentile agitation for 10 min ...
-
bioRxiv - Developmental Biology 2021Quote: ... 300 U/mL of hyaluronidase and 5 mg/mL DNAse I (StemCell Technologies) under gentile agitation for 10 min ...
-
bioRxiv - Neuroscience 2024Quote: ... and passaged every 3-5 days using ReLeSR™ (#05872; Stem Cell Technology).
-
bioRxiv - Molecular Biology 2023Quote: ... Every 4-5 days cells were passaged using ReLeSR reagent (Stemcell tech, 05872).
-
bioRxiv - Cancer Biology 2023Quote: ... pelleted cells were resuspended with pre-warmed 5 mg/ml dispase (STEMCELL Technologies) supplemented with 1:10 dilution of 1 mg/ml DNase I (STEMCELL Technologies) ...
-
bioRxiv - Molecular Biology 2023Quote: ... supplemented with a final concentration of 5 μM XAV-939 (STEMCELL Technologies, #72672) on 1:100 geltrex (GIBCO ...
-
bioRxiv - Molecular Biology 2021Quote: ... 2 million cells were passaged per each well using Accutase (StemCell Technologies) into the STEMdiff SMADi neural induction medium (StemCell Technologies) ...
-
bioRxiv - Cancer Biology 2021Quote: ... 20 ng/ml basic-FGF and 2 μg/ml Heparin (StemCell Technologies). L0125 and L0512 GBM tumorspheres were kindly provided by Dr ...
-
A critical role for heme synthesis and succinate in the regulation of pluripotent states transitionsbioRxiv - Developmental Biology 2022Quote: ... Cells were passaged every 2-3 days using accutase (Stemcell Technologies, #07920). Cells were then collected by centrifugation at 1200 rpm for 3 minutes and counted before seeding ...
-
bioRxiv - Cancer Biology 2021Quote: ... 20 ng/ml basic-FGF and 2 μg/ml Heparin (StemCell Technologies). S24 Tdtomato/GFP cells were kindly gifted by Dr ...
-
bioRxiv - Neuroscience 2022Quote: ... Heparin solution 2 μg/ml (cat# 07980, Stem Cell Technologies, Vancouver, Canada), EGF 20 ng/ml (Cat#315-09 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and fed IL-2 (50 U/mL; Stem Cell Technologies, Vancouver, Canada) every 48 hours ...
-
bioRxiv - Molecular Biology 2023Quote: ... HUDEP 2 cells were cultured in Stemspan Media (SFEM II - STEMCELL Technologies) with 50ng/ml SCF (ImmunoTools) ...
-
Most L1CAM is not associated with extracellular vesicles in human biofluids and iPSC–derived neuronsbioRxiv - Neuroscience 2024Quote: ... using STEMdiff™ APEL™2 serum-free differentiation medium (StemCell Technologies) supplemented with bFGF (10 ng/ml ...
-
bioRxiv - Bioengineering 2024Quote: ... Wells were coated with 2 mL of anti-adhesion solution (Stemcell Technologies) for 30 minutes according to the manufacturer’s protocol ...
-
bioRxiv - Cell Biology 2024Quote: ... and supplemented with Heparin solution 2 μg/mL (#07980, Stem Cell Technologies), EGF 20 ng/mL ...
-
bioRxiv - Cancer Biology 2020Quote: ... unfractionated nucleated BM cells (5×105) were suspended in methylcellulose medium (M3231, StemCell Technologies) with 0.1 ...
-
bioRxiv - Cancer Biology 2020Quote: ... unfractionated nucleated BM cells (5×105) were suspended in methylcellulose medium (M3231, StemCell Technologies) with 0.01 ng/ml murine GM-CSF (Peprotech ...
-
bioRxiv - Biochemistry 2022Quote: ... Cells were passaged every 5-7 days using ReLeSR (STEMCELL Technologies, Vancouver, BC, Canada) and maintained within passages 20 to 50.
-
bioRxiv - Bioengineering 2021Quote: ... coiled-coil containing protein kinase (ROCK) inhibitor (5 μM, StemCell Technologies, Vancouver, BC, Canada). Until 95% confluency was reached ...
-
bioRxiv - Cancer Biology 2022Quote: ... at a density of 5×103 cells/ml in Complete MammoCult Medium (StemCell Technologies). After seven days ...
-
bioRxiv - Neuroscience 2023Quote: ... iPSCs were passaged every 5-6 days using ReLeSR dissociation reagent (STEMCELL Technologies, 05872) and used for hematopoietic stem cell differentiation with STEMdiff Hematopoietic kit (STEMCELL Technologies ...
-
bioRxiv - Molecular Biology 2022Quote: ... at 37°C and passaged every 5-6 days using ReLeSR (Stem Cell Technologies).
-
bioRxiv - Developmental Biology 2024Quote: ... iPSCs lines were passaged every 5 days using Gentle Cell Dissociation Reagent (Stemcell Technologies) and plated in mTesr1 in the presence of 10 uM Y-27632 (Stemcell Technologies) ...
-
bioRxiv - Cell Biology 2023Quote: ... Routine passaging was performed every 4-5 days using ReLeSR (Cat. # 05873; STEMCELL Technologies) according to manufacturer’s instructions in E8/VTN or by treatment with Collagenase IV (Cat ...
-
bioRxiv - Genetics 2024Quote: ... Cells were differentiated for 5 days with the STEMDiff hepatocyte kit (Stem Cell Technologies), according to the manufacturer’s instructions ...
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... Cell passaging was done every 5-6 days with ReLeSR™ (Stem Cell Technologies) according to the manufacturer’s instructions ...
-
bioRxiv - Cell Biology 2024Quote: ... cells were manually dissociated by pipetting with dispase (5 U, Stem Cell Technologies, 07913) and DNase (100 μg ...
-
bioRxiv - Neuroscience 2023Quote: ... organoids were cultured in maturation media (base media further supplemented with 200 µM ascorbic acid, 500 µM Dibutyryl-cyclic adenosine monophosphate (dbcAMP, STEMCELL Technologies, cat. no 100-0244), 10 ng/ml human brain derived neurothropic factor (hBDNF ...
-
bioRxiv - Bioengineering 2021Quote: ... and 100ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2, STEMCELL Technologies, 78003.1) in RPMI 1640 for 2 days ...
-
bioRxiv - Bioengineering 2021Quote: ... and 100ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2, STEMCELL Technologies, 78003.1) for 2 days ...
-
bioRxiv - Microbiology 2021Quote: ... About 2×105 cells were washed twice in Robosep buffer (#20104, Stemcell Technologies) and fixed in 300 μl CellFix buffer 1X (#340181 ...
-
bioRxiv - Neuroscience 2021Quote: ... medium was replaced with 2 mL/well iHSC Medium B (StemCell Technologies #05310). An additional 1 mL/well of iHSC Medium B was added every other day ...
-
bioRxiv - Cancer Biology 2020Quote: ... thawed organoids were rinsed with 2% fetal bovine serum (FBS, from STEMCELL Technologies) in Hank’s Balanced Salt Solution (HF) ...
-
bioRxiv - Genetics 2020Quote: ... Expansion phase medium for HUDEP-2 cells consists of SFEM (Stemcell Technologies #09650) base medium supplemented with 50 ng/ml recombinant human SCF (R&D systems #255-SC) ...
-
bioRxiv - Genomics 2020Quote: HUDEP-2 cell lines were cultured in StemSpan™ SFEM II (STEMCELL Technologies) along with 50 ng/ml SCF (ImmunoTools) ...
-
bioRxiv - Genomics 2021Quote: ... 2×107 T cells were aliquoted into CryoStor cryopreservation media (Stem Cell technologies) for long-term storage.
-
bioRxiv - Neuroscience 2024Quote: ... Wash Solution 2 was composed of 96% BrainPhys Neuronal Medium (StemCell Technologies: 5790), 1X N2 (ThermoFisher ...
-
bioRxiv - Bioengineering 2024Quote: ... supplemented with 10 ng/mL of Human Recombinant IL-2 (STEMCELL TECHNOLOGIES, #78220) and ImmunoCult™ Human CD3/CD28 T Cell Activator (STEMCELL TECHNOLOGIES ...
-
bioRxiv - Neuroscience 2023Quote: ... and PINK1 p.I368N-2# (1067#) were cultured using mTeSR (STEMCELL Technologies, Catlog #85850) media on Matrigel (Corning ...
-
bioRxiv - Cancer Biology 2023Quote: ... the media was supplemented with 2 μg/ml heparin (STEMCELL Technologies; Cat #07980). When cells reached confluency ...
-
bioRxiv - Neuroscience 2023Quote: ... and supplemented with WNT pathway inhibitor IWP-2 (2.5 μM; STEMCELL Technologies, 72124) and recombinant Human/Murine/Rat Activin A (50 ng ml−1 ...
-
bioRxiv - Bioengineering 2024Quote: ... supplemented with 10 ng/mL recombinant IL-2 (StemCell Technologies Inc, cat#78036.1). T cells were removed from CD3/CD28 plate coating after 48 hours of incubation and moved to uncoated wells ...
-
bioRxiv - Cell Biology 2024Quote: ... Cells were cultured for 2 days in StemSpan (Stem Cell Technologies, Cat. 09655) supplemented with TPO (100ng/mL) ...
-
bioRxiv - Neuroscience 2024Quote: ... with 2 % (v/v) of SM1 Neuronal Supplement (5711, STEMCELL Technologies Inc., Germany) and 0,5 % (v/v ...
-
bioRxiv - Immunology 2024Quote: ... to 20 ml before layering over 2 x 4ml lymphoprep (Stem Cell Technologies) and centrifuging at 800 x g for 20 mins ...
-
bioRxiv - Bioengineering 2024Quote: ... and 200 IU / mL recombinant human IL-2 (STEMCELL Technologies, Canada, Catalog # 78220). Unless specified otherwise ...
-
bioRxiv - Developmental Biology 2022Quote: ... dissociated into single cells (accutase, Stemcell Technologies, 07920, 30-60 min, 37 °C, 5% CO2) and fixed (Foxp3/Transcription Factor Staining Buffer Set ...
-
bioRxiv - Genomics 2022Quote: ... the media was replaced with mTeSR1 supplemented with 5 uM of CHIR99021 (STEMCELL Tech., 72052) for 24 hours ...